STRATµM
LIVE

Serial Number

97559973

Owner

Adare Pharmaceuticals USA, Inc.

Attorney

C. Blair Barbieri

First Use Date

Aug 22, 2014

Filing Date

Aug 23, 2022

Add to watchlist:

No watchlists yet
View on USPTO

STRATµM Trademark

Serial Number: 97559973 • Registration: 7068545

STRATµM is a trademark filed by Adare Pharmaceuticals USA, Inc. on August 23, 2022. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Adare Pharmaceuticals USA, Inc. (5 trademarks)

7722 Dungan Road
Philadelphia, PA 19111

Entity Type: 03

Trademark Details

Filing Date

August 23, 2022

Registration Date

May 30, 2023

First Use Anywhere

August 22, 2014

First Use in Commerce

August 22, 2014

Published for Opposition

March 14, 2023

Goods & Services

Manufacturing services for others in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, and delayed release systems, clinical manufacturing of drug formulations for others to support clinical trials, fabrication and preparation of active pharmaceutical ingredients for others, technology scale-up services for others, and integration of technology into manufacturing processes for others, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables, all for injectable delivery

Pharmaceutical drug delivery technology development services; pharmaceutical drug delivery technology development services, namely, research and development in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, and delayed release systems, consisting of selection of drug formulation and delivery systems to optimize performance of active pharmaceutical ingredients, analytic techniques to test drug formulations, analytic services to detect, identify and quantify drug components, stability testing, physical characterization of drug formulations, in-vitro release testing, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables, all for injectable delivery

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 14, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 14, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 14, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 14, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 14, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 14, 2025 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 30, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
May 30, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 14, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 14, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 22, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 7, 2023 CNSA
ASSIGNED TO EXAMINER
Feb 6, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 12, 2022 NWOS
NEW APPLICATION ENTERED
Aug 26, 2022 NWAP